Status:
COMPLETED
Linguistically-Tailored Mobile Intervention for the Improvement of Follow Up for Abnormal Pap Test Results
Lead Sponsor:
Thomas Jefferson University
Conditions:
Cervical Carcinoma
Eligibility:
FEMALE
21-65 years
Phase:
NA
Brief Summary
This clinical trial evaluates the feasibility of a linguistically-tailored mobile intervention, called CervixChat in improving the follow-up of patients with abnormal Papanicolaou (pap) test results. ...
Detailed Description
PRIMARY OBJECTIVE: I. To evaluate the feasibility of CervixChat intervention in a mix method design, through participants consent rate and the study completion rate. SECONDARY OBJECTIVE: I. To eval...
Eligibility Criteria
Inclusion
- Female, aged 21 to 65 years of age
- Had received an abnormal Pap smear result
- Scheduled colposcopy
- Able to communicate with ease in English or Spanish
- Have a cell phone with text (TXT) ability
- Competent to give consent
Exclusion
- Are pregnant at the time of recruitment
- Display current evidence of positive invasive carcinoma of the cervix
Key Trial Info
Start Date :
February 18 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 10 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04821297
Start Date
February 18 2021
End Date
September 10 2021
Last Update
April 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sidney Kimmel Cancer Center at Thomas Jefferson University
Philadelphia, Pennsylvania, United States, 19107